The Immigration Laws and Policy in the United States of America

Figure S3. Line plot of the absolute number of cells per lymphocyte subset in 68 non-converting and 17 converting patients with arthralgia. The non-converting patients are depicted from the time point of inclusion. The converting patients are depicted from the time point of conversion and the time before conversion. (TIF 1784 kb

Additional file 1: Table S1. of Type I interferon response gene expression in established rheumatoid arthritis is not associated with clinical parameters

List of the 19 IFN response genes measured. Table S2. Results of analysis for associations between IFN scores and clinical parameters after 1000 times of random sampling using only patients who were not treated with prednisone, HCQ, or SSZ. (PDF 82 kb

Additional file 2: of Changes in peripheral blood lymphocyte subsets during arthritis development in arthralgia patients

Figure S2. Dot plots of the absolute number of cells in the lymphocyte subsets in 37 healthy controls (HC), 40 patients with arthralgia who developed arthritis within 5 years (converters), 73 patients with arthralgia who did not develop arthritis (non-converters) and 89 patients with early RA (EAC). The black line represents median of the whole group. Differences between groups were tested with the Kruskal-Wallis test followed by Dunn’s multiple comparison test. N.S. not significant. (TIF 791 kb

Additional file 1: Table S1. of Physiological evidence for diversification of IFNι- and IFNβ-mediated response programs in different autoimmune diseases

List of 23 type I interferon (IFN) response genes that were measured. Table S2. List of genes that are significantly differentially expressed between patients with systemic lupus erythematosus (SLE) and patients with multiple sclerosis (MS) who were treated with IFNβ. (PDF 116 kb